The league completes its third phase of expansion, in which each of the eight existing teams protects three additional ...
Data from HAELO Phase 3 clinical trial presented today in a late-breaking oral session at European Academy of Allergy & Clinical Immunology ...
Susanna Tapani is staying put in Boston, and the Seattle Torrent re-signed forward Julia Gosling in opening the next phase of ...
India, June 14 -- Researchers at Amsterdam UMC, working alongside several partner hospitals, have completed the world's first ...
Updated ELVN-001 results showed strong molecular response rates in previously treated CML patients, while the FDA aligned ...
Pirtobrutinib plus venetoclax-rituximab reduced progression/death risk versus venetoclax-rituximab alone in R/R CLL/SLL, with higher undetectable MRD rates at 10–6. Head-to-head FLT3 inhibition in ...
First phase 3 results from CARTITUDE-4: Cilta-cel versus standard of care (PVd or DPd) in lenalidomide-refractory multiple myeloma. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results